Preventing type 2 diabetes.
The rapid and often relentless progression of type 2 diabetes suggests that high-risk patients should be provided with an equally aggressive strategy to protect their remaining beta-cell function and endogenous insulin secretion. Management of patients with prediabetes should incorporate both lifestyle and pharmacologic intervention. Although no specific recommendations are published for the management of prediabetes, one can assume that preservation of pancreatic beta-cell function, improvement in peripheral insulin resistance and pancreatic insulin secretion, reducing pancreatic alpha-cell secretion of glucagon, preventing long- and short-term diabetes-related complications, and assisting patients to loose weight are beneficial. Aggressive, timely, and physiologic management of prediabetes should be advocated.
Unger
Jeff
J
Catalina Research Institute, 12598 Central Avenue, Chino, CA 91710, USA. jungermd@aol.com
Moriarty
Cynthia
C
D001521:Behavior Therapy / Q000379:methods; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000517:prevention & control* / Q000628:therapy; D004032:Diet; D015444:Exercise; D015438:Health Behavior; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D011320:Primary Health Care; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors; D014481:United States; D015431:Weight Loss
D007004:Hypoglycemic Agents